J Neurol Neurosurg Psychiatry 90:507513 Collatz A, Johnston SC, Staines DR, Marshall-Gradisnik SM (2016) A systematic review of drug therapies for chronic fatigue syndrome/myalgic encephalomyelitis
Research shows BPC-157 increases the stimulation of blood vessels through VEFG, upregulates early growth response genes, and increases nitric oxide through NOS3 stimulation.[ref] Here are a few of the studies in detail: A 2014 study outlined one mechanism of action, showing that BPC-157 enhances growth hormone receptors directly in the tendon, increasing growth hormone in the tendon
Likewise, decreased gene expression of Egr was evident at 24 h in the inferior caval vein, Vegfr expression was decreased at 1 h and 24 h in all vessels, and Plc gene expression was decreased at 24 h in the inferior caval vein
While both fall under the broader category of peptide therapies, they serve very different purposes
What you can't do is reconstitute, leave it at room temperature for 6 hours, then dose